5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
Recruiting · NCT05317000 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-06-10 | NCT05317000 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Barbara Burtness | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 62 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale University | New Haven | United States | 44 |